GE Develops Precision Medicine at New Marlborough Facility
New England Council Member General Electric is at the forefront of precision medicine at its Marlborough GE Healthcare Life Sciences headquarters. The recently-opened facility is developing tools for the future of precision medicine manufacturing. It will soon house GE’s ninth FlexFactory, able to “produce small batch, end-to-end biologic manufacturing solutions using single-use technologies that can be scalable for large populations.”
In addition, the facility will work on cell therapy medicine, which produces individualized batches of drugs for a single patient. While not widely available today, GE expects cell therapy to play a large role in the future, predicting their spending on the technology to increase tenfold over the next decade. Phil Vanek, general manager of cell therapy technologies at GE Healthcare said, “We have to invent new technologies. We have to rethink what a customer’s workflow would look like today, but more importantly what a customer’s workflow would be like that in the future.”
The New England Council is excited to see the advances in precision medicine from GE.